DOCSLIB.ORG

2018 Joint Meeting Program

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2018 Joint Meeting Program THE PREMIER ANNUAL MEETING FOR PHYSICIAN-SCIENTISTS APRIL 20 – 22, 2018 This activity is jointly provided by Harvard Medical School. FAIRMONT CHICAGO MILLENNIUM PARK CHICAGO, ILLINOIS www.jointmeeting.org SPECIAL EVENTS AT THE 2018 AAP / ASCI / APSA JOINT MEETING FRIDAY, APRIL 20 ASCI President’s Reception in Honor of the 20th Anniversary of the Stanley J. Korsmeyer Award 6:00 p.m. – 7:15 p.m. Gold Room ASCI Dinner & New Member Induction Ceremony (Ticketed event) 7:30 p.m. – 9:30 p.m. Rouge, Lobby Level Invited Speaker: George Q. Daley, MD, PhD, Harvard Medical School APSA Welcome Reception (Ticketed event, ID required) 9:00 p.m. – Midnight Mid-America Club, Aon Center (Off-site) SATURDAY, APRIL 21 ASCI Food & Science Evening (ID required) 6:30 p.m. – 9:00 p.m. Mid-America Club, Aon Center (Off-site) Featuring Poster Presentations by the ASCI’s 2018 Young Physician-Scientist Awardees AAP Member and New Member Induction Banquet (Ticketed event, formal attire required) 7:00 p.m. – 9:30 p.m. Imperial Ballroom, Level B2 Data Sharing in the Setting of Clinical Trials Invited Speaker: Jeffrey M. Drazen, MD, Editor-in-Chief, New England Journal of Medicine APSA Dinner & Founder’s Award Presentation (Ticketed event) 7:30 p.m. – 9:00 p.m. Rouge, Lobby Level Founder’s Award Recipient: Dania Daye, MD, PhD, Massachusetts General Hospital Charting Your Path as a Physician Scientist Dinner Speaker: Juliane Bubeck-Wardenburg, MD, PhD, Washington University School of Medicine Dessert Reception & Best Poster Awards (Open to all attendees) 9:45 p.m. – 11:30 p.m. Imperial Lobby, Level B2 SUNDAY, APRIL 22 APSA Residency Luncheon 12:30 p.m. – 2:30 p.m. International Ballroom PROGRAM CONTENTS General Program Information 2 ____________________________________________________________________________________ Continuing Medical Education Information 3 ____________________________________________________________________________________ Joint Program Planning Committee & APSA Events Committee 4 ____________________________________________________________________________________ Scientific Program Schedule 5 ____________________________________________________________________________________ Speaker Biographies 13 ____________________________________________________________________________________ Call for Nominations: 2019 Harrington Prize for Innovation in Medicine 19 ____________________________________________________________________________________ 2018 AAP/ASCI/APSA Leadership 20 ____________________________________________________________________________________ Travel Award Recipients 21 ____________________________________________________________________________________ Call for Nominations: George M. Kober Medal 23 ____________________________________________________________________________________ Oral Presentations & Poster Abstracts 24 ____________________________________________________________________________________ Oral Presentations & Poster Abstracts Author Index 137 ____________________________________________________________________________________ Hotel Floor Plans 142 ____________________________________________________________________________________ Joint Meeting Sponsors Inside Back Cover ____________________________________________________________________________________ Future Joint Meeting Dates Back Cover ____________________________________________________________________________________ www.jointmeeting.org 1 GENERAL PROGRAM INFORMATION Registration Desk Hours Poster Session Schedule Friday, April 20 7:00 a.m. – 6:30 p.m. Friday, April 20 Saturday, April 21 7:00 a.m. – 5:00 p.m. ϭϬ͗ϬϬĂ͘ŵ͘ʹϯ͗ϬϬƉ͘ŵ͘ WŽƐƚĞƌ^ĞƚƵƉ ϲ͗ϭϱƉ͘ŵ͘ʹϵ͗ϯϬƉ͘ŵ͘ /ŶĨŽƌŵĂůsŝĞǁŝŶŐ͗ƉƌĞƐĞŶƚĞƌƐĚŽŶŽƚ Sunday, April 22 7:30 a.m. – 10:00 a.m. ŶĞĞĚƚŽďĞĂƚƉŽƐƚĞƌ Saturday, April 21 Americans with Disabilities Act dtKWŽƐƚĞƌWƌĞƐĞŶƚĂƟŽŶ^ĞƐƐŝŽŶƐ ǀĞŶƚƐƚĂīǁŝůůďĞŐůĂĚƚŽĂƐƐŝƐƚLJŽƵǁŝƚŚĂŶLJƐƉĞĐŝĂůŶĞĞĚƐ ϴ͗ϬϬĂ͘ŵ͘ʹϵ͗ϬϬĂ͘ŵ͘ WŽƐƚĞƌ^ĞƐƐŝŽŶǁŝƚŚ ;ŝ͘Ğ͕͘ ƉŚLJƐŝĐĂů͕ ĚŝĞƚĂƌLJ͕ ĞƚĐ͘Ϳ͘ WůĞĂƐĞ ĐŽŶƚĂĐƚ ƚŚĞ ZĞŐŝƐƚƌĂƟŽŶ ŽŶƟŶĞŶƚĂůƌĞĂŬĨĂƐƚ ĞƐŬĂƚƚŚĞŵĞĞƟŶŐŝĨLJŽƵƌĞƋƵŝƌĞĂŶLJƐƉĞĐŝĂůĂƐƐŝƐƚĂŶĐĞ͘ ODD numbered posters presented Joint Meeting Evaluations ϭϭ͗ϰϱĂ͘ŵ͘ʹϭ͗ϯϬƉ͘ŵ͘ WŽƐƚĞƌ^ĞƐƐŝŽŶǁŝƚŚ>ƵŶĐŚ EVEN numbered posters presented dŚĞWͬ^/ͬW^:ŽŝŶƚDĞĞƟŶŐWůĂŶŶŝŶŐ ŽŵŵŝƩĞĞƌĞůŝĞƐ ϭ͗ϯϬƉ͘ŵ͘ʹϮ͗ϬϬƉ͘ŵ͘ WŽƐƚĞƌŝƐŵĂŶƚůĞ ŽŶ LJŽƵƌ ŝŶƉƵƚ ƚŽ ĞŶŚĂŶĐĞ ŝƚƐ ŵĞĞƟŶŐƐ͘ &ŽůůŽǁŝŶŐ ƚŚĞ :ŽŝŶƚ DĞĞƟŶŐ͕ĂŶŽŶůŝŶĞŵĞĞƟŶŐĞǀĂůƵĂƟŽŶǁŝůůďĞĞŵĂŝůĞĚƚŽĂůů ϵ͗ϰϱƉ͘ŵ͘ʹϭϭ͗ϯϬƉ͘ŵ͘ ĞƐƚWŽƐƚĞƌǁĂƌĚƐ ĂƩĞŶĚĞĞƐ͘ W^ ĂƩĞŶĚĞĞƐ ǁŝůů ƌĞĐĞŝǀĞ Ă ƐĞƉĂƌĂƚĞ ƐƵƌǀĞLJ ƚŽ ;ĚƵƌŝŶŐĞƐƐĞƌƚZĞĐĞƉƟŽŶŝŶ ŚĞůƉŝƚƐƉůĂŶŶŝŶŐĐŽŵŵŝƩĞĞĞŶŚĂŶĐĞW^ͲƐƉŽŶƐŽƌĞĚĞǀĞŶƚƐ /ŵƉĞƌŝĂů&ŽLJĞƌͿ ĂƚĨƵƚƵƌĞWͬ^/ͬW^:ŽŝŶƚDĞĞƟŶŐƐ͘zŽƵƌƉĂƌƟĐŝƉĂƟŽŶŝŶ WŽƐƚĞƌƉƌĞƐĞŶƚĞƌƐƐŚŽƵůĚƉůĂŶƚŽďĞĂǀĂŝůĂďůĞŽŶ^ĂƚƵƌĚĂLJĨŽƌ ƚŚŝƐƐƵƌǀĞLJŝƐŐƌĞĂƚůLJĂƉƉƌĞĐŝĂƚĞĚ͘ ƚŚĞŝƌĂƉƉŽŝŶƚĞĚƉŽƐƚĞƌƉƌĞƐĞŶƚĂƟŽŶƐĞƐƐŝŽŶĂŶĚƚŚĞƌĞƐƵůƟŶŐ ĂǁĂƌĚƐƉƌŽŐƌĂŵůĂƚĞƌŝŶƚŚĞĞǀĞŶŝŶŐ͘ AAP/ASCI/APSA Joint Meeting Code of Conduct Best Poster Awards tĞǀĂůƵĞLJŽƵƌĂƩĞŶĚĂŶĐĞ͘KƵƌĐŽŶĨĞƌĞŶĐĞŝƐĚĞĚŝĐĂƚĞĚƚŽ ĞƐƚWŽƐƚĞƌǁĂƌĚƐǁŝůůďĞŐŝǀĞŶŝŶƚŚĞĂŵŽƵŶƚŽĨΨϭ͕ϬϬϬĞĂĐŚ͘ ƉƌŽǀŝĚŝŶŐĂŚĂƌĂƐƐŵĞŶƚͲĨƌĞĞĞdžƉĞƌŝĞŶĐĞĨŽƌĞǀĞƌLJŽŶĞ͕ƌĞŐĂƌĚůĞƐƐ DĞŵďĞƌƐ ŽĨ ƚŚĞ W͕ ^/ ĂŶĚ W^ ǁŝůů ũƵĚŐĞ ƉŽƐƚĞƌƐ ŽŶ ŽĨŐĞŶĚĞƌ͕ŐĞŶĚĞƌŝĚĞŶƟƚLJĂŶĚĞdžƉƌĞƐƐŝŽŶ͕ĂŐĞ͕ƐĞdžƵĂůŽƌŝĞŶƚĂƟŽŶ͕ ƐĐŝĞŶƟĮĐŶŽǀĞůƚLJ͕ƋƵĂůŝƚLJĂŶĚĐůĂƌŝƚLJŽĨƉƌĞƐĞŶƚĂƟŽŶ͘ǁĂƌĚƐǁŝůů ĚŝƐĂďŝůŝƚLJ͕ ƉŚLJƐŝĐĂů ĂƉƉĞĂƌĂŶĐĞ͕ ďŽĚLJ ƐŝnjĞ͕ ƌĂĐĞ͕ ĞƚŚŶŝĐŝƚLJ͕ Žƌ ďĞƉƌĞƐĞŶƚĞĚŽŶ^ĂƚƵƌĚĂLJ͕ƉƌŝůϮϭ͕ĨƌŽŵϵ͗ϰϱƉ͘ŵ͘ʹϭϭ͗ϯϬƉ͘ŵ͘ ƌĞůŝŐŝŽƵƐƉƌĞĨĞƌĞŶĐĞ͘Wͬ^/ͬW^ĚŽŶŽƚƚŽůĞƌĂƚĞŚĂƌĂƐƐŵĞŶƚ WŽƐƚĞƌ ƉƌĞƐĞŶƚĞƌƐ ƐŚŽƵůĚ ƉůĂŶ ŽŶ ĂƩĞŶĚŝŶŐ ĨŽƌ ĂǁĂƌĚ ŽĨĐŽŶĨĞƌĞŶĐĞƉĂƌƟĐŝƉĂŶƚƐŝŶĂŶLJĨŽƌŵ͘ƉĂƌƟĐŝƉĂŶƚĞŶŐĂŐŝŶŐ ƉƌĞƐĞŶƚĂƟŽŶ͘ ŝŶŚĂƌĂƐƐŝŶŐďĞŚĂǀŝŽƌǁŝůůďĞǁĂƌŶĞĚĂŶĚŵĂLJďĞĂƐŬĞĚƚŽůĞĂǀĞ ƚŚĞĐŽŶĨĞƌĞŶĐĞǁŝƚŚŶŽƌĞĨƵŶĚ͘/ĨLJŽƵĂƌĞďĞŝŶŐŚĂƌĂƐƐĞĚ͕ŶŽƟĐĞ ƚŚĂƚƐŽŵĞŽŶĞĞůƐĞŝƐďĞŝŶŐŚĂƌĂƐƐĞĚ͕ŽƌŚĂǀĞĂŶLJŽƚŚĞƌĐŽŶĐĞƌŶƐ͕ ƉůĞĂƐĞĐŽŶƚĂĐƚĂŵĞŵďĞƌŽĨĐŽŶĨĞƌĞŶĐĞƐƚĂīĂƚƚŚĞƌĞŐŝƐƚƌĂƟŽŶ ĚĞƐŬŝŵŵĞĚŝĂƚĞůLJ͘ŽŶĨĞƌĞŶĐĞƐƚĂīĂŶĚŽƌŐĂŶŝnjĞƌƐĂƌĞĚĞĚŝĐĂƚĞĚ ƚŽ ŵĂŬŝŶŐ Ăůů ƉĂƌƟĐŝƉĂŶƚƐ ĨĞĞů ƐĂĨĞ ĨŽƌ ƚŚĞ ĚƵƌĂƟŽŶ ŽĨ ƚŚĞ ĐŽŶĨĞƌĞŶĐĞ͘ 2 2018 AAP / ASCI / APSA Joint Meeting CONTINUING MEDICAL EDUCATION INFORMATION Continuing Medical Education (CME) Accreditation Statement Information dŚŝƐĂĐƟǀŝƚLJŚĂƐďĞĞŶƉůĂŶŶĞĚĂŶĚŝŵƉůĞŵĞŶƚĞĚŝŶĂĐĐŽƌĚĂŶĐĞ dŚĞ Wͬ^/ͬW^ :ŽŝŶƚ DĞĞƟŶŐ ĂŶŶƵĂůůLJ ďƌŝŶŐƐ ƚŽŐĞƚŚĞƌ ǁŝƚŚ ƚŚĞ ĂĐĐƌĞĚŝƚĂƟŽŶ ƌĞƋƵŝƌĞŵĞŶƚƐ ĂŶĚ ƉŽůŝĐŝĞƐ ŽĨ ƚŚĞ ƉŚLJƐŝĐŝĂŶͲƐĐŝĞŶƟƐƚƐŽĨĂůůďĂĐŬŐƌŽƵŶĚƐƚŽŚŝŐŚůŝŐŚƚƐŽŵĞŽĨƚŚĞ ĐĐƌĞĚŝƚĂƟŽŶŽƵŶĐŝůĨŽƌŽŶƟŶƵŝŶŐDĞĚŝĐĂůĚƵĐĂƟŽŶ;DͿ ďĞƐƚĞdžĂŵƉůĞƐŽĨƚƌĂŶƐůĂƟŽŶĂůďŝŽŵĞĚŝĐĂůƌĞƐĞĂƌĐŚ͕ƚŽĐĞůĞďƌĂƚĞ ƚŚƌŽƵŐŚƚŚĞũŽŝŶƚƉƌŽǀŝĚĞƌƐŚŝƉŽĨ,ĂƌǀĂƌĚDĞĚŝĐĂů^ĐŚŽŽůĂŶĚ ŶĞǁŵĞŵďĞƌƐĞůĞĐƚĞĚƚŽƚŚĞWĂŶĚ^/ŝŶƌĞĐŽŐŶŝƟŽŶŽĨ ƚŚĞƐƐŽĐŝĂƟŽŶŽĨŵĞƌŝĐĂŶWŚLJƐŝĐŝĂŶƐ͕ƚŚĞŵĞƌŝĐĂŶ^ŽĐŝĞƚLJ ƚŚĞŝƌƌĞƐĞĂƌĐŚĂŶĚůĞĂĚĞƌƐŚŝƉĐŽŶƚƌŝďƵƟŽŶƐ͕ĂŶĚƚŽƌĞĐŽŐŶŝnjĞ ĨŽƌůŝŶŝĐĂů/ŶǀĞƐƟŐĂƟŽŶ͕ĂŶĚƚŚĞŵĞƌŝĐĂŶWŚLJƐŝĐŝĂŶ^ĐŝĞŶƟƐƚƐ ƚŚĞĐĂƌĞĞƌƐŽĨƉŚLJƐŝĐŝĂŶͲƐĐŝĞŶƟƐƚƐǁŚŽŚĂǀĞŚĂĚŵĂũŽƌŝŵƉĂĐƚ ƐƐŽĐŝĂƟŽŶ͘dŚĞ,ĂƌǀĂƌĚDĞĚŝĐĂů^ĐŚŽŽůŝƐĂĐĐƌĞĚŝƚĞĚďLJƚŚĞ ŽŶƚŚĞŝƌĮĞůĚƐ͘ DƚŽƉƌŽǀŝĚĞĐŽŶƟŶƵŝŶŐŵĞĚŝĐĂůĞĚƵĐĂƟŽŶĨŽƌƉŚLJƐŝĐŝĂŶƐ͘ Meeting Learning Objectives AMA Credit Designation Statement dŚĞ ,ĂƌǀĂƌĚ DĞĚŝĐĂů ^ĐŚŽŽů ĚĞƐŝŐŶĂƚĞƐ ƚŚŝƐ ůŝǀĞ ĂĐƟǀŝƚLJ ĨŽƌ hƉŽŶĐŽŵƉůĞƟŽŶŽĨƚŚŝƐĂĐƟǀŝƚLJ͕ƉĂƌƟĐŝƉĂŶƚƐǁŝůůďĞĂďůĞƚŽ͗ Ă ŵĂdžŝŵƵŵ ŽĨ ϴ AMA PRA Category 1 CreditsΡ͘ WŚLJƐŝĐŝĂŶƐ x ǀĂůƵĂƚĞŝŵƉŽƌƚĂŶƚƌĞĐĞŶƚĂĚǀĂŶĐĞƐŝŶƚŚĞƐĐŝĞŶƟĮĐďĂƐŝƐŽĨ ƐŚŽƵůĚĐůĂŝŵŽŶůLJƚŚĞĐƌĞĚŝƚĐŽŵŵĞŶƐƵƌĂƚĞǁŝƚŚƚŚĞĞdžƚĞŶƚŽĨ ĚŝƐĞĂƐĞĂŶĚƚŚĞƌĂƉLJ͘ ƚŚĞŝƌƉĂƌƟĐŝƉĂƟŽŶŝŶƚŚĞĂĐƟǀŝƚLJ͘ x ŽŶƐŝĚĞƌ ŶŽǀĞů ƐƚƌĂƚĞŐŝĞƐ ƚŽ ĂĚĚƌĞƐƐ ĐŚĂůůĞŶŐĞƐ ƚŽ ƚŚĞ ƉŚLJƐŝĐŝĂŶͲƐĐŝĞŶƟƐƚ͘ Claiming CME Credit and Obtaining x ĞƚĞƌŵŝŶĞƚŚĞƌŽůĞƐƚŚĂƚŝŵƉƌŽǀĞĚƵŶĚĞƌƐƚĂŶĚŝŶŐŽĨƚŚĞƐĞ Certificates ĂĚǀĂŶĐĞƐĂŶĚƐƚƌĂƚĞŐŝĞƐĐĂŶƉůĂLJŝŶƚŚĞƉŽƚĞŶƟĂůƚƌĞĂƚŵĞŶƚ WĂƌƟĐŝƉĂŶƚƐǁŝůůďĞƐĞŶƚĂůŝŶŬƚŽƚŚĞŽŶůŝŶĞĞǀĂůƵĂƟŽŶďĞĨŽƌĞ ŽĨŚƵŵĂŶĚŝƐĞĂƐĞ͘ ƚŚĞƐƚĂƌƚŽĨƚŚĞŵĞĞƟŶŐĂŶĚǁŝůůďĞƌĞƋƵŝƌĞĚƚŽĐŽŵƉůĞƚĞƚŚĞ ŽŶůŝŶĞĞǀĂůƵĂƟŽŶƚŽƌĞĐĞŝǀĞDĐƌĞĚŝƚ͘KŶĐĞƚŚĞĞǀĂůƵĂƟŽŶ Target Audience ŝƐĐŽŵƉůĞƚĞĚ͕ƉĂƌƟĐŝƉĂŶƚƐŵĂLJƉƌŝŶƚ͕ƐĂǀĞ͕ŽƌĞŵĂŝůƚŚĞŝƌD dŚŝƐ ĂĐƟǀŝƚLJ ŝƐ ƚĂƌŐĞƚĞĚ ƚŽǁĂƌĚƐ ƉŚLJƐŝĐŝĂŶͲƐĐŝĞŶƟƐƚƐ͕ ƚƌĂŝŶĞĞƐ ĐĞƌƟĮĐĂƚĞƐ Žƌ ĐĞƌƟĮĐĂƚĞƐ ŽĨ ĂƩĞŶĚĂŶĐĞ ;ĨŽƌ ŶŽŶͲƉŚLJƐŝĐŝĂŶƐͿ͘ ĂŶĚ ƐƚƵĚĞŶƚƐ ĂĐƌŽƐƐ Ă ďƌŽĂĚ ƌĂŶŐĞ ŽĨ ƐƉĞĐŝĂůƟĞƐ ŝŶĐůƵĚŝŶŐ YƵĞƐƟŽŶƐƌĞůĂƚĞĚƚŽƚŚŝƐĂĐƟǀŝƚLJŽƌŽŶĐŽŵƉůĞƟŶŐƚŚŝƐŽŶůŝŶĞ ďĂƐŝĐ ƌĞƐĞĂƌĐŚ͕ ĐĂƌĚŝŽůŽŐLJͬĐĂƌĚŝŽǀĂƐĐƵůĂƌ ƌĞƐĞĂƌĐŚ͕ ĐĞůů ĂŶĚ ĞǀĂůƵĂƟŽŶŵĂLJďĞĚŝƌĞĐƚĞĚƚŽĐĞƉƌŽŐƌĂŵƐΛŚŵƐ͘ŚĂƌǀĂƌĚ͘ĞĚƵ. ŵŽůĞĐƵůĂƌ ďŝŽůŽŐLJ͕ ĞŶĚŽĐƌŝŶĞ ĂŶĚ ŵĞƚĂďŽůŝƐŵ͕ ŚĞŵĂƚŽůŽŐLJ͕ ŝŵŵƵŶŽůŽŐLJ͕ ŝŶĨĞĐƟŽƵƐ ĚŝƐĞĂƐĞƐ͕ ŶĞƉŚƌŽůŽŐLJ͕ ƉƵůŵŽŶŽůŽŐLJ͕ Disclaimer ĂŶĚŽƚŚĞƌƐ͘ DĂĐƟǀŝƟĞƐƐƉŽŶƐŽƌĞĚďLJ,ĂƌǀĂƌĚDĞĚŝĐĂů^ĐŚŽŽůĂƌĞŽīĞƌĞĚ ƐŽůĞůLJĨŽƌĞĚƵĐĂƟŽŶĂůƉƵƌƉŽƐĞƐĂŶĚĚŽŶŽƚĐŽŶƐƟƚƵƚĞĂŶLJĨŽƌŵ HMS Disclosure Policy ŽĨ ĐĞƌƟĮĐĂƟŽŶ ŽĨ ĐŽŵƉĞƚĞŶĐLJ͘ WƌĂĐƟƟŽŶĞƌƐ ƐŚŽƵůĚ ĂůǁĂLJƐ ,D^ ĂĚŚĞƌĞƐ ƚŽ Ăůů ĐĐƌĞĚŝƚĂƟŽŶ ŽƵŶĐŝů ĨŽƌ ŽŶƟŶƵŝŶŐ ĐŽŶƐƵůƚ ĂĚĚŝƟŽŶĂů ƐŽƵƌĐĞƐ ŽĨ ŝŶĨŽƌŵĂƟŽŶ ĂŶĚ ĞdžĞƌĐŝƐĞ ƚŚĞŝƌ DĞĚŝĐĂůĚƵĐĂƟŽŶ;DͿĐĐƌĞĚŝƚĂƟŽŶƌŝƚĞƌŝĂĂŶĚWŽůŝĐŝĞƐ͘ ďĞƐƚƉƌŽĨĞƐƐŝŽŶĂůũƵĚŐŵĞŶƚďĞĨŽƌĞŵĂŬŝŶŐĐůŝŶŝĐĂůĚĞĐŝƐŝŽŶƐŽĨ /ƚŝƐ,D^͛ƐƉŽůŝĐLJƚŚĂƚƚŚŽƐĞǁŚŽŚĂǀĞŝŶŇƵĞŶĐĞĚƚŚĞĐŽŶƚĞŶƚ ĂŶLJŬŝŶĚ͘dŚĞĐŽŶƚĞŶƚŽĨĞĂĐŚƉƌĞƐĞŶƚĂƟŽŶĚŽĞƐŶŽƚŶĞĐĞƐƐĂƌŝůLJ ŽĨ Ă D ĂĐƟǀŝƚLJ ;Ğ͘Ő͘ ƉůĂŶŶĞƌƐ͕ ĨĂĐƵůƚLJ͕ ĂƵƚŚŽƌƐ͕ ƌĞǀŝĞǁĞƌƐ ƌĞŇĞĐƚƚŚĞǀŝĞǁƐŽĨ,ĂƌǀĂƌĚDĞĚŝĐĂů^ĐŚŽŽů͘ ĂŶĚ ŽƚŚĞƌƐͿ ĚŝƐĐůŽƐĞ Ăůů ƌĞůĞǀĂŶƚ ĮŶĂŶĐŝĂů ƌĞůĂƟŽŶƐŚŝƉƐ ǁŝƚŚ ĐŽŵŵĞƌĐŝĂůĞŶƟƟĞƐƐŽƚŚĂƚ,D^ŵĂLJŝĚĞŶƟĨLJĂŶĚƌĞƐŽůǀĞĂŶLJ ĐŽŶŇŝĐƚƐŽĨŝŶƚĞƌĞƐƚƉƌŝŽƌƚŽƚŚĞĂĐƟǀŝƚLJ͘dŚĞƐĞĚŝƐĐůŽƐƵƌĞƐǁŝůů ďĞƉƌŽǀŝĚĞĚŝŶƚŚĞĂĐƟǀŝƚLJŵĂƚĞƌŝĂůƐĨŽƌƚŚĞůĞĂƌŶĞƌƐĂůŽŶŐǁŝƚŚ ĚŝƐĐůŽƐƵƌĞŽĨĂŶLJĐŽŵŵĞƌĐŝĂůƐƵƉƉŽƌƚƌĞĐĞŝǀĞĚĨŽƌƚŚĞĂĐƟǀŝƚLJ ƉƌŝŽƌƚŽƚŚĞďĞŐŝŶŶŝŶŐŽĨƚŚĞĂĐƟǀŝƚLJ͘ ,D^ ƐƚƌŝǀĞƐ ƚŽ ĞŶƐƵƌĞ ƚŚĂƚ ƚŚĞ ĐŽŶƚĞŶƚ ŽĨ Ăůů ŝƚƐ ĂĐĐƌĞĚŝƚĞĚ ĂĐƟǀŝƟĞƐ ŝƐ ŝŶĚĞƉĞŶĚĞŶƚ ĨƌŽŵ ĂŶLJ ĐŽŵŵĞƌĐŝĂů ŝŶŇƵĞŶĐĞ͕ ƉƌĞƐĞŶƚƐĂďĂůĂŶĐĞŽĨƚŚĞƌĂƉĞƵƟĐŽƉƟŽŶƐ͕ƉƌŽŵŽƚĞƐŝŵƉƌŽǀĞͲ ŵĞŶƚƐŝŶŚĞĂůƚŚĐĂƌĞĂŶĚŝƐŝŶĂůŝŐŶŵĞŶƚǁŝƚŚƚŚĞDŽŶƚĞŶƚ sĂůŝĚĂƟŽŶ WŽůŝĐLJ͘ ĚĚŝƟŽŶĂůůLJ͕ ĨĂĐƵůƚLJ ŵĞŵďĞƌƐ ŚĂǀĞ ďĞĞŶ ŝŶƐƚƌƵĐƚĞĚƚŽĚŝƐĐůŽƐĞĂŶLJůŝŵŝƚĂƟŽŶƐŽĨĚĂƚĂĂŶĚƵŶůĂďĞůĞĚŽƌ ŝŶǀĞƐƟŐĂƟŽŶĂů ƵƐĞƐ ŽĨ ƉƌŽĚƵĐƚƐ͕ ƉŚĂƌŵĂĐĞƵƟĐĂůƐ Žƌ ŵĞĚŝĐĂů ĚĞǀŝĐĞƐĚƵƌŝŶŐƚŚĞŝƌƉƌĞƐĞŶƚĂƟŽŶƐ͘ www.jointmeeting.org 3 JOINT PROGRAM PLANNING COMMITTEE & APSA EVENTS COMMITTEE Joint Program Planning Committee Members APSA Events Committee From the AAP: WƌĞƐŝĚĞŶƚ Jillian Liu (6th year MD/PhD) WWƌĞƐŝĚĞŶƚ Ohio State University Serpil Erzurum, MD Cleveland Clinic
Load more

Recommended publications
  • Supplemental Material Table of Contents
    Supplemental material Table of Contents Detailed Materials and Methods ......................................................................................................... 2 Perioperative period ........................................................................................................................... 2 Ethical aspects ................................................................................................................................... 4 Evaluation of heart failure ................................................................................................................. 4 Sample preparation for ANP mRNA expression .................................................................................. 5 Sample preparation for validative qRT-PCR (Postn, Myh7, Gpx3, Tgm2) ............................................ 6 Tissue fibrosis .................................................................................................................................... 7 Ventricular remodeling and histological tissue preservation ................................................................ 8 Evaluation of the histological preservation of cardiac tissue ................................................................ 9 Sample preparation and quantitative label-free proteomics analyses .................................................. 10 Statistical methods ........................................................................................................................... 12 References ........................................................................................................................................
    [Show full text]
  • Neurons That Regulate Mouse Torpor
    Article Neurons that regulate mouse torpor https://doi.org/10.1038/s41586-020-2387-5 Sinisa Hrvatin1,6 ✉, Senmiao Sun1,2,6, Oren F. Wilcox1, Hanqi Yao1, Aurora J. Lavin-Peter1, Marcelo Cicconet3, Elena G. Assad1, Michaela E. Palmer1, Sage Aronson4, Received: 22 January 2020 Alexander S. Banks5, Eric C. Griffith1 & Michael E. Greenberg1 ✉ Accepted: 7 May 2020 Published online: xx xx xxxx The advent of endothermy, which is achieved through the continuous homeostatic Check for updates regulation of body temperature and metabolism1,2, is a defning feature of mammalian and avian evolution. However, when challenged by food deprivation or harsh environmental conditions, many mammalian species initiate adaptive energy-conserving survival strategies—including torpor and hibernation—during which their body temperature decreases far below its homeostatic set-point3–5. How homeothermic mammals initiate and regulate these hypothermic states remains largely unknown. Here we show that entry into mouse torpor, a fasting-induced state with a greatly decreased metabolic rate and a body temperature as low as 20 °C6, is regulated by neurons in the medial and lateral preoptic area of the hypothalamus. We show that restimulation of neurons that were activated during a previous bout of torpor is sufcient to initiate the key features of torpor, even in mice that are not calorically restricted. Among these neurons we identify a population of glutamatergic Adcyap1-positive cells, the activity of which accurately determines when mice naturally initiate and exit torpor, and the inhibition of which disrupts the natural process of torpor entry, maintenance and arousal. Taken together, our results reveal a specifc neuronal population in the mouse hypothalamus that serves as a core regulator of torpor.
    [Show full text]
  • Entosis Enables a Population Response to Starvation
    www.impactjournals.com/oncotarget/ Oncotarget, 2017, Vol. 8, (No. 35), pp: 57934-57935 Editorial Entosis enables a population response to starvation Jens C. Hamann and Michael Overholtzer Commentary on: Hamann et al. Entosis is induced by glucose starvation. Cell Rep. 2017; 20:201-210. https://doi.org/10.1016/j. celrep.2017.06.037 Cell death isn’t just about apoptosis anymore. In cells in a population to scavenge extracellular nutrients and the last decade, numerous alternative mechanisms have accumulate the biomass necessary to support proliferation emerged, including regulated forms of necrosis, as well (Figure 1). Macropinocytosis has been shown to act as entosis, a unique mechanism that is executed as a cell similarly to allow cancer cells to scavenge extracellular murder rather than cell suicide [1]. Hamann et al. now proteins [5]. Entosis instead supplies bulk nutrients in identify glucose starvation as a key inducer of this non- the form of whole cells, where, on average, winner cells cell-autonomous form of cell death [2]. ingest two losers, providing a large nutrient supply that Cells that undergo entosis are killed as a result of is well suited to support the outgrowth of selected cells ingestion into their neighbors. They are not phagocytosed, in the population. Indeed, winners with ingested losers but rather form junctions with their neighbors and then have a nearly 10-fold proliferative advantage, and entosis invade into them, ultimately becoming killed through a is required for population re-growth during long-term mechanism involving autophagy proteins and lysosomal starvation. enzymes [1, 3]. This is a competitive process that results Our findings identify entosis as a population-scale in elimination of stiffer cells (“losers”) by softer ones starvation response with parallels to cell competition (“winners”), an effect linked to control over entotic cell occurring in developing tissues [6].
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Regulation of Expression and Activity of the Bhlh-PAS Transcription
    Regulation of Expression and Activity of the bHLH-PAS Transcription Factor NPAS4 David Christopher Bersten B.Sc. (Biomedical Science), Honours (Biochemistry) A thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy Discipline of Biochemistry School of Molecular and Biomedical Science University of Adelaide, Australia June 2014 1 Contents Abstract ................................................................................................................................................... 3 PhD Thesis Declaration ........................................................................................................................... 5 Acknowledgements ................................................................................................................................. 6 Publications ............................................................................................................................................. 8 Conference oral presentations ........................................................................................................... 9 Additional publications ....................................................................................................................... 9 Chapter 1: .............................................................................................................................................. 10 Introduction .....................................................................................................................................
    [Show full text]
  • G-Protein-Coupled Receptor Signaling and Polarized Actin Dynamics Drive
    RESEARCH ARTICLE elifesciences.org G-protein-coupled receptor signaling and polarized actin dynamics drive cell-in-cell invasion Vladimir Purvanov, Manuel Holst, Jameel Khan, Christian Baarlink, Robert Grosse* Institute of Pharmacology, University of Marburg, Marburg, Germany Abstract Homotypic or entotic cell-in-cell invasion is an integrin-independent process observed in carcinoma cells exposed during conditions of low adhesion such as in exudates of malignant disease. Although active cell-in-cell invasion depends on RhoA and actin, the precise mechanism as well as the underlying actin structures and assembly factors driving the process are unknown. Furthermore, whether specific cell surface receptors trigger entotic invasion in a signal-dependent fashion has not been investigated. In this study, we identify the G-protein-coupled LPA receptor 2 (LPAR2) as a signal transducer specifically required for the actively invading cell during entosis. We find that 12/13G and PDZ-RhoGEF are required for entotic invasion, which is driven by blebbing and a uropod-like actin structure at the rear of the invading cell. Finally, we provide evidence for an involvement of the RhoA-regulated formin Dia1 for entosis downstream of LPAR2. Thus, we delineate a signaling process that regulates actin dynamics during cell-in-cell invasion. DOI: 10.7554/eLife.02786.001 Introduction Entosis has been described as a specialized form of homotypic cell-in-cell invasion in which one cell actively crawls into another (Overholtzer et al., 2007). Frequently, this occurs between tumor cells such as breast, cervical, or colon carcinoma cells and can be triggered by matrix detachment (Overholtzer et al., 2007), suggesting that loss of integrin-mediated adhesion may promote cell-in-cell invasion.
    [Show full text]
  • Identification of Novel Potential Genes Involved in Cancer by Integrated
    International Journal of Molecular Sciences Article Identification of Novel Potential Genes Involved in Cancer by Integrated Comparative Analyses Francesco Monticolo 1, Emanuela Palomba 2 and Maria Luisa Chiusano 1,2,* 1 Department of Agricultural Sciences, Università Degli Studi di Napoli Federico II, 80055 Naples, Italy; [email protected] 2 Department of RIMAR, Stazione Zoologica “Anton Dohrn”, 80122 Naples, Italy; [email protected] * Correspondence: [email protected] Received: 26 October 2020; Accepted: 11 December 2020; Published: 15 December 2020 Abstract: The main hallmarks of cancer diseases are the evasion of programmed cell death, uncontrolled cell division, and the ability to invade adjacent tissues. The explosion of omics technologies offers challenging opportunities to identify molecular agents and processes that may play relevant roles in cancer. They can support comparative investigations, in one or multiple experiments, exploiting evidence from one or multiple species. Here, we analyzed gene expression data from induction of programmed cell death and stress response in Homo sapiens and compared the results with Saccharomyces cerevisiae gene expression during the response to cell death. The aim was to identify conserved candidate genes associated with Homo sapiens cell death, favored by crosslinks based on orthology relationships between the two species. Weidentified differentially-expressed genes, pathways that are significantly dysregulated across treatments, and characterized genes among those involved in induced cell death. We investigated on co-expression patterns and identified novel genes that were not expected to be associated with death pathways, that have a conserved pattern of expression between the two species. Finally, we analyzed the resulting list by HumanNet and identified new genes predicted to be involved in cancer.
    [Show full text]
  • Maria Barthmes, Andre Bazzone, Ulrich Thomas, Andrea Brüggemann, Michael George, Niels Fertig, Alison Obergrussberger
    Label-free analysis of Na+/Ca2+- exchanger (NCX) isolated from iPSC-derived cardiomyocytes Maria Barthmes, Andre Bazzone, Ulrich Thomas, Andrea Brüggemann, Michael George, Niels Fertig, Alison Obergrussberger Nanion Technologies GmbH, Ganghoferstr. 70A, 80339 Munich, Germany, contact: [email protected] Abstract Measuring NCX activity in human iPSC derived The Sodium-Calcium Exchangers (NCX) play an To drive the progress in pharmacological NCX cardiomyocytes important role in the cellular calcium research, new methods to measure NCX Human iPSC derived cardiomyocytes are being with high fluidic speed, the cells detached homeostasis under physiological and function are needed. At the current time, investigated as a model for cardiac safety again, but a sheet of the cell membrane pathological conditions. NCX has been of functional investigation of NCX range from assessment. To measure native NCX in these remains on the sensor. NCX currents can be interest as a pharmacological target for many patch-clamp, calcium flux assays, Langendorff- cardiomyocytes a cell based assay was evoked in these sheets. For a higher NCX signal years, in particular because clinical trials perfused hearts to studies in whole animals. We developed. Cardiomyocytes were detached female cardiomyocytes were used. This method involving inhibitors of the sodium-proton have developed an electrophysiological from the culture dish and added to the lipid enables the efficient investigation of the isolated exchanger, NHE, have delivered mixed results. method to investigate NCX function which is coated SSM sensor. Where the cell connected cardiac NCX current in a native membrane. Inhibition of the reversed mode of NCX is based on the solid supported membrane (SSM) with the lipid layer.
    [Show full text]
  • Early-Stage Dynamics of Chloride Ion–Pumping Rhodopsin Revealed by a Femtosecond X-Ray Laser
    Early-stage dynamics of chloride ion–pumping rhodopsin revealed by a femtosecond X-ray laser Ji-Hye Yuna,1, Xuanxuan Lib,c,1, Jianing Yued, Jae-Hyun Parka, Zeyu Jina, Chufeng Lie, Hao Hue, Yingchen Shib,c, Suraj Pandeyf, Sergio Carbajog, Sébastien Boutetg, Mark S. Hunterg, Mengning Liangg, Raymond G. Sierrag, Thomas J. Laneg, Liang Zhoud, Uwe Weierstalle, Nadia A. Zatsepine,h, Mio Ohkii, Jeremy R. H. Tamei, Sam-Yong Parki, John C. H. Spencee, Wenkai Zhangd, Marius Schmidtf,2, Weontae Leea,2, and Haiguang Liub,d,2 aDepartment of Biochemistry, College of Life Sciences and Biotechnology, Yonsei University, Seodaemun-gu, 120-749 Seoul, South Korea; bComplex Systems Division, Beijing Computational Science Research Center, Haidian, 100193 Beijing, People’s Republic of China; cDepartment of Engineering Physics, Tsinghua University, 100086 Beijing, People’s Republic of China; dDepartment of Physics, Beijing Normal University, Haidian, 100875 Beijing, People’s Republic of China; eDepartment of Physics, Arizona State University, Tempe, AZ 85287; fPhysics Department, University of Wisconsin, Milwaukee, Milwaukee, WI 53201; gLinac Coherent Light Source, Stanford Linear Accelerator Center National Accelerator Laboratory, Menlo Park, CA 94025; hDepartment of Chemistry and Physics, Australian Research Council Centre of Excellence in Advanced Molecular Imaging, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia; and iDrug Design Laboratory, Graduate School of Medical Life Science, Yokohama City University, 230-0045 Yokohama, Japan Edited by Nicholas K. Sauter, Lawrence Berkeley National Laboratory, Berkeley, CA, and accepted by Editorial Board Member Axel T. Brunger February 21, 2021 (received for review September 30, 2020) Chloride ion–pumping rhodopsin (ClR) in some marine bacteria uti- an acceptor aspartate (13–15).
    [Show full text]
  • Classification of Cell Death
    Cell Death and Differentiation (2009) 16, 3–11 & 2009 Macmillan Publishers Limited All rights reserved 1350-9047/09 $32.00 www.nature.com/cdd Review Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009 G Kroemer*,1,2,3, L Galluzzi1,2,3, P Vandenabeele4,5, J Abrams6, ES Alnemri7, EH Baehrecke8, MV Blagosklonny9, WS El-Deiry10, P Golstein11,12,13, DR Green14, M Hengartner15, RA Knight16, S Kumar17, SA Lipton18,19,20, W Malorni21, G Nun˜ez22, ME Peter23, J Tschopp24, J Yuan25, M Piacentini26,27, B Zhivotovsky28 and G Melino29,30 Different types of cell death are often defined by morphological criteria, without a clear reference to precise biochemical mechanisms. The Nomenclature Committee on Cell Death (NCCD) proposes unified criteria for the definition of cell death and of its different morphologies, while formulating several caveats against the misuse of words and concepts that slow down progress in the area of cell death research. Authors, reviewers and editors of scientific periodicals are invited to abandon expressions like ‘percentage apoptosis’ and to replace them with more accurate descriptions of the biochemical and cellular parameters that are actually measured. Moreover, at the present stage, it should be accepted that caspase-independent mechanisms can cooperate with (or substitute for) caspases in the execution of lethal signaling pathways and that ‘autophagic cell death’ is a type of cell death occurring together with (but not necessarily by) autophagic vacuolization. This study details the 2009 recommendations of the NCCD on the use of cell death-related terminology including ‘entosis’, ‘mitotic catastrophe’, ‘necrosis’, ‘necroptosis’ and ‘pyroptosis’.
    [Show full text]
  • SUPPLEMENTARY NOTE Co-Activation of GR and NFKB
    SUPPLEMENTARY NOTE Co-activation of GR and NFKB alters the repertoire of their binding sites and target genes. Nagesha A.S. Rao1*, Melysia T. McCalman1,*, Panagiotis Moulos2,4, Kees-Jan Francoijs1, 2 2 3 3,5 Aristotelis Chatziioannou , Fragiskos N. Kolisis , Michael N. Alexis , Dimitra J. Mitsiou and 1,5 Hendrik G. Stunnenberg 1Department of Molecular Biology, Radboud University Nijmegen, the Netherlands 2Metabolic Engineering and Bioinformatics Group, Institute of Biological Research and Biotechnology, National Hellenic Research Foundation, Athens, Greece 3Molecular Endocrinology Programme, Institute of Biological Research and Biotechnology, National Hellenic Research Foundation, Greece 4These authors contributed equally to this work 5 Corresponding authors E-MAIL: [email protected] ; TEL: +31-24-3610524; FAX: +31-24-3610520 E-MAIL: [email protected] ; TEL: +30-210-7273741; FAX: +30-210-7273677 Running title: Global GR and NFKB crosstalk Keywords: GR, p65, genome-wide, binding sites, crosstalk SUPPLEMENTARY FIGURES/FIGURE LEGENDS AND SUPPLEMENTARY TABLES 1 Rao118042_Supplementary Fig. 1 A Primary transcript Mature mRNA TNF/DMSO TNF/DMSO 8 12 r=0.74, p< 0.001 r=0.61, p< 0.001 ) 2 ) 10 2 6 8 4 6 4 2 2 0 Fold change (mRNA) (log Fold change (primRNA) (log 0 −2 −2 −2 0 2 4 −2 0 2 4 Fold change (RNAPII) (log2) Fold change (RNAPII) (log2) B chr5: chrX: 56 _ 104 _ DMSO DMSO 1 _ 1 _ 56 _ 104 _ TA TA 1 _ 1 _ 56 _ 104 _ TNF TNF Cluster 1 1 _ Cluster 2 1 _ 56 _ 104 _ TA+TNF TA+TNF 1 _ 1 _ CCNB1 TSC22D3 chr20: chr17: 25 _ 33 _ DMSO DMSO 1 _ 1 _ 25 _ 33 _ TA TA 1 _ 1 _ 25 _ 33 _ TNF TNF Cluster 3 1 _ Cluster 4 1 _ 25 _ 33 _ TA+TNF TA+TNF 1 _ 1 _ GPCPD1 CCL2 chr6: chr22: 77 _ 35 _ DMSO DMSO 1 _ 77 _ 1 _ 35 _ TA TA 1 _ 1 _ 77 _ 35 _ TNF Cluster 5 Cluster 6 TNF 1 _ 1 _ 77 _ 35 _ TA+TNF TA+TNF 1 _ 1 _ TNFAIP3 DGCR6 2 Supplementary Figure 1.
    [Show full text]
  • Optogenetics and Its Application in Neural Degeneration and Regeneration
    3/13/2018 Optogenetics and its application in neural degeneration and regeneration Neural Regen Res. 2017 Aug; 12(8): 1197–1209. PMCID: PMC5607808 doi: 10.4103/1673-5374.213532 Optogenetics and its application in neural degeneration and regeneration Josue D. Ordaz,1,2,3 Wei Wu,1,2,3 and Xiao-Ming Xu, M.D., Ph.D.1,2,3,4,* 1 Spinal Cord and Brain Injury Research Group, Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA 2 Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, IN, USA 3 Goodman Campbell Brain and Spine, Indianapolis, Indiana, USA 4 Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, USA * Correspondence to: Xiao-Ming Xu, [email protected]. Author contributions: JDO wrote the paper. JDO and WW were responsible for making figures and edited the paper. XMX reviewed and edited the paper. All authors participated in the conception of this study and approved the final version of this paper. Accepted 2017 Jul 11. Copyright : © Neural Regeneration Research This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. Abstract Neural degeneration and regeneration are important topics in neurological diseases. There are limited options for therapeutic interventions in neurological diseases that provide simultaneous spatial and temporal control of neurons. This drawback increases side effects due to non-specific targeting.
    [Show full text]